Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Endocrine 1
| Generic Name | Brand Name | Pharmacologic Category | Common Indications | Key Side Effects/Other Notes | US Boxed Warning |
|---|---|---|---|---|---|
| metformin (PO) | Glucophage, Glucophage XR | Biguanide | Type 2 DM, PCOS | Key Side Effects: diarrhea, nausea, vomiting | US Boxed Warning: lactic acidosis |
| sitagliptin (PO) | Januvia | Dipeptidyl peptidase (DPP-4) inhibitor | Type 2 DM | Key Side Effects: headache, nasopharyngitis | |
| empagliflozin (PO) | Jardiance | Sodium-glucose cotransporter inhibitor 2 (SGLT2 inhibitor) | Type 2 DM, HF | Key Side Effects: UTI | |
| glimepiride (PO) | Amaryl | Sulfonylurea | Type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| glipizide (PO) | Glucotrol, Glucotrol XL | Sulfonylurea | Type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| glyburide (PO) | Glynase | Sulfonylurea | Type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| pioglitazone (PO) | Actos | Thiazolidinedione (TZD) | Type 2 DM | Key Side Effects: edema, weight gain, upper respiratory tract infection | US Boxed Warning: may exacerbate congestive heart failure and Cl in NYHA Class III and IV |
| liraglutide (SQ) | Victoza, Saxenda | Glucagon-like peptide-1 (GLP-1) receptor agonist | Type 2 DM, chronic weight management | Key Side Effects: nausea, vomiting, diarrhea, constipation | US Boxed Warning: may increase risk of thyroid c-cell tumor |
| insulin detemir (SQ) | Levemir | Insulin, long acting | Type 1 DM, type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| insulin glargine (SQ) | Lantus, Toujeo, Basaglar | Insulin, long acting | Type 1 DM, type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| insulin NPH (SQ) | Humulin N, Novolin N | Insulin, intermediate acting | Type 1 DM, type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| insulin aspart (SQ) | Novolog | Insulin, rapid acting | Type 1 DM, type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| insulin lispro (SQ) | Humalog | Insulin, rapid acting | Type 1 DM, type 2 DM | Key Side Effects: hypoglycemia, weight gain | |
| insulin regular (SQ, IV) | Humulin R, Novolin R | Insulin, short-acting | Type 1 DM, type 2 DM, DKA | Key Side Effects: hypoglycemia, weight gain | |
| levothyroxine (PO, IV) | Synthroid, Levoxyl | Thyroid product | Hypothyroidism | Key Side Effects: weight loss, palpitations, diarrhea, insomnia, heat intolerance Other Notes: narrow therapeutic index drug (therapeutic monitoring is recommended); not all generic products are therapeutically equivalent | US Boxed Warning: not intended for use for weight loss |
| thyroid, dessicated (PO) | Armour Thyroid | Thyroid product | Hypothyroidism | Key Side Effects: weight loss, palpitations, diarrhea, insomnia, heat intolerance Other Notes: narrow therapeutic index drug (therapeutic monitoring is recommended); not all generic products are therapeutically equivalent | US Boxed Warning: not intended for use for weight loss |
| sitagliptin and metformin (PO) | Janumet, Janumet XR | sitagliptin: Dipeptidyl peptidase (DPP-4) inhibitor metformin (PO): Biguanide | sitagliptin: Type 2 DM metformin (PO): Type 2 DM, PCOS | Key Side Effects (Sitagliptin): headache, nasopharyngitis Key Side Effects (Metformin): diarrhea, nausea, vomiting | US Boxed Warning (Metformin): lactic acidosis |
Created by:
brookenicole1496
Popular Pharmacology sets